Applications to the Fiscal Year 2015 (FY15) Reconstructive Transplant Research (RTR) program) are being solicited for the Defense Health Agency, Research, Development, and Acquisition (DHA RDA) Directorate, by the U.S. Army Medical Research Acquisition Activity (USAMRAA). As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the DHA RDA Directorate manages and executes the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. This Program Announcement/Funding Opportunity and subsequent awards will be managed and executed by the Congressionally Directed Medical Research Programs (CDMRP) with strategic oversight from Joint Program Committee 8/Clinical and Rehabilitative Medicine Research Program (JPC-8/CRMRP). To meet the intent of the FY15 RTR award mechanisms, applicants must address one or more of the Focus Areas listed below. â€˘ Immune system regulation â€˘ Improved access to reconstructive transplantation â€˘ Reconstructive transplantation rehabilitation â€˘ Graft surveillance â€“ Clinical monitoring â€˘ Psychosocial issues associated with VCA. The RTR Idea Discovery Award (RTR IDA) mechanism is being offered for the first time in FY15. A synopsis of all FY15 RTR Program Announcements/Funding Opportunities is available at http://cdmrp.army.mil/funding/pdf/15rtrpreftable.pdf. The intent of the RTR IDA is to support innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods relevant to RT. Studies supported by this award are expected to develop robust data that will lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design. The Idea Discovery Award is not intended to support a logical progression of an already established research project. The proposed research project should be novel and innovative. Innovative research may introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities. Research that is an incremental advance upon published data is not considered innovative and will not be considered for funding under this award mechanism.